TKTakashi Kadowaki

Takashi Kadowaki

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Takashi Kadowaki has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Toshimasa Yamauchi

    Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

    2 shared publications
  • Akira Okada

    Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

    1 shared publication
  • Kayo Ikeda Kurakawa

    Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

    1 shared publication
  • Kazuyuki Tobe

    First Department of Internal Medicine, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, Toyama, Japan

    1 shared publication
  • Maria Overvad

    Novo Nordisk A/S, Søborg, Denmark

    1 shared publication
  • Masaomi Nangaku

    Division of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

    1 shared publication

Latest Publications

  • Open Access

    Clinical characteristics affecting weight loss in an East Asian population receiving semaglutide: A STEP 6 subgroup analysis

    by Takashi Kadowaki, Sang Yeoup Lee, Wataru Ogawa, Tomoyuki Nishida, Maria Overvad, Kazuyuki Tobe, Toshimasa Yamauchi, Soo Lim


  • Open Access

    Impact of COVID-19 pandemic on healthcare service use for non-COVID-19 patients in Japan: retrospective cohort study

    by Satoko Yamaguchi, Akira Okada, Shinji Sunaga, Kayo Ikeda Kurakawa, Toshimasa Yamauchi, Masaomi Nangaku, Takashi Kadowaki

    Objectives We aimed to investigate the impact of the first and second waves of the COVID-19 pandemic on healthcare service use by non-COVID-19 patients. Design Retrospective cohort study. Setting Hospital-based claims database from anonymised hospitals in Japan. Participants Patients (n=785 495) who visited and/or were hospitalised in 26 anonymised hospitals in Japan between January 2017 and November 2020. Outcome measures We compared changes in the monthly number of hospitalisations (overall or by diagnosis), outpatient visits, endoscopic fibrescopies (EFs), rehabilitations, outpatient chemotherapy treatments, maintenance haemodialysis treatments and outpatient prescriptions between pre-COVID-19 years and the same period in 2020. Results The overall number of hospitalisations and outpatient visits decreased by 27% and 22%, respectively, in May 2020, of which the most substantial decrease was observed in the paediatrics department (65% and 51%, respectively). The number of hospitalisations for respiratory diseases, circulatory diseases, malignant neoplasms and digestive diseases decreased by a maximum of 55%, 32%, 10% and 26%, respectively, in 2020. The number of hospitalisations for non-COVID-19 pneumonia in patients aged 30%. In contrast, outpatient chemotherapy and maintenance haemodialysis treatments decreased by Conclusions The use of healthcare services by non-COVID-19 patients was most affected during the first wave of the COVID-19 pandemic in May 2020. The number of hospitalisations for respiratory diseases, particularly non-COVID-19 pneumonia and asthma, drastically decreased, while the number of hospitalisations and outpatient chemotherapies for malignant neoplasms or maintenance haemodialysis was less affected.